115 related articles for article (PubMed ID: 20585876)
1. Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers.
Lee MC; Eatrides J; Chau A; Han G; Kiluk JV; Khakpour N; Cox CE; Carter WB; Laronga C
Ann Surg Oncol; 2011 Jan; 18(1):72-7. PubMed ID: 20585876
[TBL] [Abstract][Full Text] [Related]
2. The SAVE review: sonographic analysis versus excision for axillary staging in breast cancer.
Henry-Tillman R; Glover-Collins K; Preston M; Gallagher K; Tummel E; Robertson YV; Ochoa D; Korourian S; Westbrook K; Klimberg VS
J Am Coll Surg; 2015 Apr; 220(4):560-7. PubMed ID: 25797740
[TBL] [Abstract][Full Text] [Related]
3. Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling.
Wellington J; Sanders T; Mylander C; Alden A; Harris C; Buras R; Tafra L; Liang W; Stelle L; Rosman M; Jackson RS
Ann Surg Oncol; 2018 Aug; 25(8):2271-2278. PubMed ID: 29868976
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
[TBL] [Abstract][Full Text] [Related]
5. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the use of axillary ultrasound and lymph node needle biopsy with surgical lymph node pathology in patients with invasive breast cancer.
Cowher MS; Erb KM; Poller W; Julian TB
Am J Surg; 2008 Nov; 196(5):756-9. PubMed ID: 18513695
[TBL] [Abstract][Full Text] [Related]
7. The role of axillary ultrasound in the detection of metastases from primary breast cancers.
Yamashita M; Hovanessian-Larsen L; Sener SF
Am J Surg; 2013 Mar; 205(3):242-4; discussion 244-5. PubMed ID: 23369307
[TBL] [Abstract][Full Text] [Related]
8. Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.
Tucker NS; Cyr AE; Ademuyiwa FO; Tabchy A; George K; Sharma PK; Jin LX; Sanati S; Aft R; Gao F; Margenthaler JA; Gillanders WE
Ann Surg; 2016 Dec; 264(6):1098-1102. PubMed ID: 26779976
[TBL] [Abstract][Full Text] [Related]
9. Indications for axillary ultrasound use in breast cancer patients.
Joh JE; Han G; Kiluk JV; Laronga C; Khakpour N; Lee MC
Clin Breast Cancer; 2012 Dec; 12(6):433-7. PubMed ID: 23062709
[TBL] [Abstract][Full Text] [Related]
10. Does BMI affect the accuracy of preoperative axillary ultrasound in breast cancer patients?
Shah AR; Glazebrook KN; Boughey JC; Hoskin TL; Shah SS; Bergquist JR; Dupont SC; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3278-83. PubMed ID: 25074661
[TBL] [Abstract][Full Text] [Related]
11. Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients.
Holwitt DM; Swatske ME; Gillanders WE; Monsees BS; Gao F; Aft RL; Eberlein TJ; Margenthaler JA
Am J Surg; 2008 Oct; 196(4):477-82. PubMed ID: 18723153
[TBL] [Abstract][Full Text] [Related]
12. Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer.
Baruah BP; Goyal A; Young P; Douglas-Jones AG; Mansel RE
Br J Surg; 2010 May; 97(5):680-3. PubMed ID: 20186888
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound.
McEvoy AM; Poplack S; Nickel K; Olsen MA; Ademuyiwa F; Zoberi I; Odom E; Yu J; Chang SH; Gillanders WE
Breast Cancer Res Treat; 2020 Sep; 183(2):251-262. PubMed ID: 32651755
[TBL] [Abstract][Full Text] [Related]
14. Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications.
Cools-Lartigue J; Sinclair A; Trabulsi N; Meguerditchian A; Mesurolle B; Fuhrer R; Meterissian S
Ann Surg Oncol; 2013 Mar; 20(3):819-27. PubMed ID: 22972506
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
16. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
[TBL] [Abstract][Full Text] [Related]
17. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era.
Farshid G; Kollias J; Grantley Gill P
Breast Cancer Res Treat; 2015 Jun; 151(2):347-55. PubMed ID: 25904216
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
